FDA Drug Topics: Cannabis and Cannabis-Derived Products – For Healthcare Practitioners - March 28, 2023
The Adobe Connect room for this webinar can accommodate 3000 participants. If the room is full when you attempt to enter, please note that the recording of the webinar will be available on our Division of Drug Information Webinars webpage later this week and will also be available as a Home Study course providing CE credit in a few weeks.
FDA’s Division of Drug Information in the Center for Drug Evaluation and Research (CDER) is excited to present a series of educational webinars targeting the needs of all health care professionals and students, including physicians, physician assistants, nurses, pharmacists, and pharmacy technicians. Interact with FDA staff from a variety of divisions and learn more about the FDA and drug regulation!
On Tuesday, March 28, 2023, CDER's Office of Communication, Division of Drug Information (DDI) will host a webinar titled: FDA Drug Topics: Cannabis and Cannabis-Derived Products – For Healthcare Practitioners. This webinar will provide a general understanding of the Cannabis sativa L. plant and how products are generally produced utilizing cannabis raw materials. The presentation will explain why manufacturing controls surrounding cannabis and cannabis-derived products are an integral part of protecting the public health. Will provide attendees with greater knowledge of the many products available on the marketplace, a discussion on potential benefits and risks, ways to report adverse events associated with these products to FDA, as well as suggestions on how to create a safe space to discuss patient use of these products.
Download Presentation Slides: Cannabis and Cannabis-Derived Products (PDF - 4.1MB)
Activity Outline and Continuing Education Information
If you have never attended an Adobe Connect meeting before:
- Test your connection: Adobe Connect Diagnostic Test
- Get a quick overview: Discover Adobe Connect Solutions
Adobe, the Adobe logo, Acrobat and Adobe Connect are either registered trademarks or trademarks of Adobe Systems Incorporated in the United States and/or other countries.